Ironwood Pharmaceuticals (IRWD) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to -$140.4 million.
- Ironwood Pharmaceuticals' Enterprise Value fell 5917.18% to -$140.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$140.4 million, marking a year-over-year decrease of 5917.18%. This contributed to the annual value of -$88.6 million for FY2024, which is 390.11% up from last year.
- According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Enterprise Value is -$140.4 million, which was down 5917.18% from -$92.9 million recorded in Q2 2025.
- Ironwood Pharmaceuticals' Enterprise Value's 5-year high stood at -$88.2 million during Q3 2024, with a 5-year trough of -$741.6 million in Q1 2023.
- Its 5-year average for Enterprise Value is -$334.3 million, with a median of -$177.2 million in 2023.
- In the last 5 years, Ironwood Pharmaceuticals' Enterprise Value crashed by 9801.85% in 2021 and then skyrocketed by 8598.42% in 2023.
- Over the past 5 years, Ironwood Pharmaceuticals' Enterprise Value (Quarter) stood at -$621.4 million in 2021, then fell by 5.81% to -$657.5 million in 2022, then surged by 85.98% to -$92.2 million in 2023, then increased by 3.9% to -$88.6 million in 2024, then crashed by 58.55% to -$140.4 million in 2025.
- Its Enterprise Value stands at -$140.4 million for Q3 2025, versus -$92.9 million for Q2 2025 and -$108.5 million for Q1 2025.